Adeona Pharmaceuticals Inc announced today that it has initiated the US launch of its high precision diagnostic test panel for the comprehensive evaluation of zinc and copper status in patients with Alzheimer’s disease (AD) and mild cognitive impairment (MCI).
Read Moreosetta Genomics Ltd, a leading developer of microRNA-based molecular diagnostics, has announced the appointment of Kenneth A. Berlin to the position of president and CEO, effective November 2, 2009.
Read MorePerkinElmer Inc announces that the company has received 510K clearance from the FDA for its GSP Genetic Screening Processor, which is used by public health laboratories worldwide as part of newborn screening programs.
Read MoreSQI Diagnostics Inc, announced that the FDA has cleared the company’s automated SQiDworks Diagnostics Platform and its multiplexed IgXPLEX rheumatoid arthritis (RA) assay for marketing in the US.
Read More
Hospital-acquired infections exact a staggering toll.
Read More